Clinical Trial

Probiotic Treatment for Depression and Associated Mood Disorders in Parkinson's Disease

Study acronym: ProD
Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
This study evaluates the use of an oral multi-strain probiotic in the treatment of depression in individuals with Parkinson's Disease. Participants will be randomized to either a 12-week multi-strain probiotic treatment or placebo intervention.
Protocol Amendment History 2 changes
notable Primary completion pushed: 2026-12-30 -> 2027-12-31 2026-05-09
minor Completion pushed: 2026-12-30 -> 2027-12-31 2026-05-09
Trial Details
NCT Number NCT05568498
Lead Sponsor University of British Columbia
Conditions Parkinson Disease, Depression, PARKINSON DISEASE (Disorder)
Enrollment 60 participants
Start Date 2025-01-20
Primary Completion 2027-12-31 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-05-08